Key result
Artificial intelligence technologies, including machine learning and deep learning, improve predictive performance and diagnostic accuracy for venous thromboembolism compared to traditional models.
Why the study?
Despite clinical prediction models, biomarker assessments, and imaging, gaps remain in accurately identifying and managing patients at high risk for venous thromboembolism.
Artificial intelligence technologies offer promising enhancements for venous thromboembolism prevention and diagnosis, though successful integration requires rigorous prospective validation.
Answers are grounded in this paper and cite their sources.
May enhance VTE prevention and diagnosis now; leaves open integration pending rigorous prospective validation.
Venous thromboembolism (VTE), which includes deep vein thrombosis and pulmonary embolism, is a significant and preventable cause of morbidity and mortality worldwide. Despite the existence of clinical prediction models, biomarker-based risk assessments, and imaging techniques, gaps remain in accurately identifying and managing high-risk patients. In recent years, artificial intelligence has emerged as a transformative tool in healthcare, offering promising applications for enhancing VTE prevention strategies. This narrative review synthesizes current evidence on the use of artificial intelligence (AI) technologies including machine learning (ML), deep learning (DL), and natural language processing (NLP). We explore how supervised ML algorithms, such as random forests, support vector machines, and gradient boosting, improve predictive performance compared to traditional models by capturing complex, nonlinear relationships within electronic health record data. We also examine the role of DL models, particularly convolutional neural networks, in interpreting imaging data, achieving diagnostic accuracies comparable to expert radiologists. Additionally, the review highlights NLP applications in extracting risk-relevant information from unstructured clinical notes and the emerging integration of wearable device data and time-series analysis for dynamic risk assessment. We argue that the successful integration of AI into routine VTE prevention workflows requires rigorous prospective validation, cross-institutional collaboration, and thoughtful implementation into clinical decision support systems.
No takes yet. Share an insight, caveat, or question.
Crisan et al. (2026) conducted a review in Venous thromboembolism. Artificial intelligence (machine learning, deep learning, natural language processing) vs. Traditional models was evaluated. Artificial intelligence technologies, including machine learning and deep learning, improve predictive performance and diagnostic accuracy for venous thromboembolism compared to traditional models.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: